SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-019525
Filing Date
2024-05-15
Accepted
2024-05-15 08:39:34
Documents
16
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51628
2 ex99-1.htm EX-99.1 44663
3 ex99-1_001.jpg GRAPHIC 12606
  Complete submission text file 0001493152-24-019525.txt   302079

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ghsi-20240513.xsd EX-101.SCH 3033
5 XBRL LABEL FILE ghsi-20240513_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ghsi-20240513_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3812
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 24947369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)